GH Research (GHRS) Enterprise Value Growth (1y) (2021 - 2025)
GH Research (GHRS) Enterprise Value Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -104.91% |
| Sep 30, 2025 | -103.67% |
| Jun 30, 2025 | -96.65% |
| Mar 31, 2025 | -99.89% |
| Dec 31, 2024 | 10.33% |
| Sep 30, 2024 | 13.64% |
| Jun 30, 2024 | 14.86% |
| Mar 31, 2024 | 19.05% |
| Dec 31, 2023 | 19.24% |
| Sep 30, 2023 | 44.76% |
| Jun 30, 2023 | 42.87% |
| Mar 31, 2023 | 41.22% |
| Dec 31, 2022 | 40.04% |
| Sep 30, 2022 | 8.48% |
| Dec 31, 2021 | -5,535,620.00% |